Safinamide in Parkinson's Disease: A retrospective study

被引：0
|
作者：
Carmona-Abellan, M.
Erburu, M.
Cabrera, A.
Garcia-Monco, C.
Berganzo, K.
Huete, B.
机构：
来源：
MOVEMENT DISORDERS | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1378
引用
收藏
页码：S603 / S604
页数：2
相关论文
共 50 条
  • [31] Evaluation of the effectiveness of safinamide in a Spanish population with Parkinson's disease
    Freire-Alvarez, E.
    Esquivel, A.
    Gomez-Esteban, J.
    Kulisevsky-Bojarski, J.
    Legarda-Ramirez, I.
    Alvarez-Santullo, M. Mata
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 515 - 515
  • [32] Adjuvant therapies for Parkinson's disease: critical evaluation of safinamide
    Stocchi, Fabrizio
    Torti, Margherita
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 609 - 618
  • [33] Use of Safinamide as add-on therapy to levodopa-carbidopa intestinal gel in advanced Parkinson's disease: A retrospective study
    Gonzalez-Pinto Gonzalez, T.
    Gomez Esteban, J. C.
    Tijero Merino, B.
    Fernandez Valle, T.
    Campos Rodriguez, I.
    Moreno Estebanez, A.
    Agirre Beitia, G.
    Chavarri Rubio, I.
    Berganzo Corrales, K.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 641 - 641
  • [34] Clinical pharmacology review of safinamide for the treatment of Parkinson's disease
    Fabbri, Margherita
    Rosa, Mario M.
    Abreu, Daisy
    Ferreira, Joaquim J.
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2015, 5 (06) : 481 - 496
  • [35] The Efficacy of Safinamide in the Management of Parkinson's Disease: A Systematic Review
    Sharaf, Joudi
    Williams, Kerry-Ann D.
    Tariq, Maha
    Acharekar, Maitri, V
    Saldivia, Sara E. Guerrero
    Unnikrishnan, Sumedha
    Chavarria, Yeny Y.
    Akindele, Adebisi O.
    Jalkh, Ana P.
    Eastmond, Aziza K.
    Shetty, Chaitra
    Rizvi, Syed Muhammad Hannan A.
    Mohammed, Lubna
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (09)
  • [36] Assessment of the effects of safinamide on the clinical treatment of Parkinson's disease
    Guan, Zaifeng
    Gu, Jingjing
    Hu, Guifang
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2019, 125 : 292 - 292
  • [37] Safinamide: an add-on treatment for managing Parkinson's disease
    Mueller, Thomas
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2018, 10 : 31 - 41
  • [38] Safinamide improves executive functions in fluctuating Parkinson's disease patients: an exploratory study
    Rinaldi, Domiziana
    Sforza, Michela
    Assogna, Francesca
    Savini, Cinzia
    Salvetti, Marco
    Caltagirone, Carlo
    Spalletta, Gianfranco
    Pontieri, Francesco E.
    JOURNAL OF NEURAL TRANSMISSION, 2021, 128 (02) : 273 - 277
  • [39] Real life evaluation of safinamide effectiveness in Parkinson's disease
    Mancini, Francesca
    Di Fonzo, Alessio
    Lazzeri, Giulia
    Borellini, Linda
    Silani, Vincenzo
    Lacerenza, Marco
    Comi, Cristoforo
    NEUROLOGICAL SCIENCES, 2018, 39 (04) : 733 - 739
  • [40] Safinamide in the treatment of URINARY symptoms in PARKinson's disease (SURINPARK)
    Gomez Lopez, A.
    Parees Moreno, I.
    Fanjul Arbos, S.
    Lopez Sendon, J. L.
    Martinez Castrillo, J. C.
    Alonso Canovas, A.
    MOVEMENT DISORDERS, 2019, 34 : S250 - S250
12345